NRF1 and atrial fibrillation: Dong et al. (2016) have found that β3 adrenergic receptor agonists can affect the atrial mitochondrial biosynthesis and energy metabolism remodeling in experimental rabbits by modulating the PGC1-α/NRF-1 signaling pathway, which, in turn, affects the occurrence of AF [25].